Skip to content

ARA-290: Dosage & Administration

Part of the ARA-290 Complete Guide

Partner

Research Peptides

BioLongevity Labs15% Off
Shop Peptides at BioLongevity Labs

We may earn a commission if you purchase through this link, at no extra cost to you.

Dosage Protocols

IndicationDoseRouteFrequency
Neuropathy (Phase 2)2 mgSC3× weekly
Metabolic research4 mgSCDaily

ARA-290 has a plasma half-life of ~2 minutes, but tissue-level effects persist much longer through downstream IRR signaling cascades.

Preparation

Clinical trial formulations were pre-filled syringes. Research-grade ARA-290 is reconstituted from lyophilized powder with bacteriostatic water. Use the peptide calculator for volumes.

Timing & Cycles

Phase 2 trials used 28-day treatment courses. ARA-290 can be administered at any time of day. Three-times-weekly dosing was effective for neuropathy outcomes despite the short plasma half-life.

Storage

  • Lyophilized: -20°C long-term, 2–8°C short-term
  • Reconstituted: 2–8°C, use per supplier specifications

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

Related Guides

PI

Peptides Insider Editorial Team

Our content is reviewed for accuracy and grounded in peer-reviewed research where available. We do not provide medical advice. Always consult a qualified healthcare professional.